For more details and registration click here Overview This course provides endocrinologists, neurosurgeons, and other providers who care for patients with pituitary disorders with a review and update of the more controversial encountered problems in
Dr. Blevins Corner
Medical comments from Dr. Lewis Blevins MD. Director Center for Pituitary Disorders at University California San Francisco
A review of six drugs to treat hypercortisolism
Here are links to Dr. Blevins’ discussion of five drugs to treat hypercortisolism.
Medications for Cushing’s disease: a review.
We are pleased to announce a series of podcasts on the medical management of hypercortisolism.
Pituitary tumors are not brain tumors.
From the desk of PWN cofounder Lewis S. Blevins, Jr. M D – Social media has been a springboard for misinformation, and the spread of such, regarding a wide variety of topics. Politics. Sports. Education.
Webinar: The complexities of hormone levels and symptoms of pituitary conditions
Two outstanding informational webinars were made available to Pituitary World News by Dr. Lewis Blevins, co-founder and medical director of the California Center for Pituitary Disorders at UCSF Medical Center. These webinars are designed primarily
Hypercortisolism Emerging Clinical Insights
A presentation from Lewis Blevins, M.D. Pituitary World News cofounder and Medical Director of the California Center for Pituitary Disorders at UCSF on the emerging clinical insights of hypercortisolism. Click here to view the presentation.
News from the California Center for Pituitary Disorders at UCSF
From our friends at UCSF: Read this great update with links to articles on telemedicine for patients with pituitary disorders, making surgery safer during the Covid-19 pandemic, common mistakes made when treating patients with central hypothyroidism,
Follow ups: Why are they so critical?
Two cases where patients’ lack of follow-up leads to complications that likely could have been avoided.
Inquiries
Interesting inquiries prompted by the questions patients leave in their health portals.
A pituitary patient’s experience with COVID-19
A compelling, detailed account of a pituitary patient’s experience with COVID-19 everyone should listen. As the virus takes hold in what is undoubtedly the worst phase of this pandemic, we urge you to follow all
Telemedicine and COVID-19, insights from our survey
Not surprisingly, COVID-19 appears to have significantly impacted pituitary patients’ access to healthcare. Our brief survey elicited information from respondents on their experiences and attitudes towards obtaining healthcare via telemedicine. Dr. Blevins shares the findings
The unrecognized caveats of pituitary conditions
From Lewis S Blevins, Jr., M.D. – Today on Dr. Blevins’ Corner: An elderly man underwent removal of the thyroid gland many years ago due to an overactive thyroid as a result of a goiter. He
The things to take into consideration in interpreting pituitary lab results
In this eye-opening podcast, Dr. Lewis Blevins takes an in-depth look at the science of interpreting pituitary lab results and shares some of the things physicians think about when viewing results. Here’s an excerpt of